Physician profile
Michael Sperling
NPI 1508865569
$1,375.50
in general payments reported to CMS, 2019-2025
19 companies · $20.62 in 2025
The $20.62 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $792 · 2020: $319 · 2021: $148 · 2022: $95.92 · 2025: $20.62.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $20.62.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $20.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $394.64 | 2019-2022 | |
| Janssen Biotech, INC. | $171.28 | 2019-2021 | |
| Janssen Scientific Affairs, LLC | $124.20 | 2019 | |
| Gilead Sciences, INC. | $110.91 | 2019 | |
| Abbott Laboratories | $107.82 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $95.49 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $83.71 | 2019 | |
| Merck Sharp & Dohme LLC | $46.02 | 2019-2020 | |
| Portola Pharmaceuticals, LLC | $39.29 | 2019 | |
| Covidien LP | $31.30 | 2019 | |
| Allergan, INC. | $29.73 | 2019 | |
| Pfizer INC. | $27.19 | 2019-2020 | |
| Amgen INC. | $21.57 | 2019 | |
| Hologic Sales and Service, LLC | $20.62 | 2025 | Aptima |
| Alfasigma USA, INC. | $18.85 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $15.52 | 2019 | |
| Intercept Pharmaceuticals, INC. | $13.41 | 2020 | |
| Novo Nordisk INC | $12.74 | 2020 | |
| Ironwood Pharmaceuticals, INC | $11.21 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Sperling listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.